Form4insider filings, from the source

SEC Form 4 · accession 0000899243-15-009490

Amphastar Pharmaceuticals, Inc. · AMPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Mary Z. Luo
Officer — COO & Chief Scientist · Director · 10% Owner
Jack Y. Zhang
Officer — CEO & Chief Science Officer · Director · 10% Owner
Period of report
Dec 4, 2015
Accepted (ET)
Dec 8, 2015 · 7:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2,F3Dec 4, 2015S28,712$14.952D7,564,299ISee footnote
Common StockF4,F3Dec 7, 2015S15,046$14.5879D7,549,253ISee footnote
Common StockF5,F3Dec 8, 2015S24,359$14.4964D7,524,894ISee footnote
Common Stockholding———920,117D
Common StockF6holding———670,147ISee footnote
Common StockF7holding———5,000ISee footnote
Common StockF8holding———200,000ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses